ReviewJournal of clinical tuberculosis and other mycobacterial diseases2021

The pipeline of new molecules and regimens against drug-resistant tuberculosis.

Todd A Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.